image description

Foad Hoseinian

European Counsel

Foad Hoseinian

European Counsel
Brussels +32-2896-8028 +32-2896-8028 +32-2896-8099 +32-2896-8099
[email protected]
Foad Hoseinian is a European counsel in the Brussels office, advising clients on global merger and antitrust investigations, drawing authority from his unique litigation experience. Prior to re-joining private practice in 2012, Foad clerked with judge Nils Wahl at the General Court of the EU for six years. Foad is a member of ICC’s merger working group as well as CCBE’s permanent delegation to the Court of Justice of the EU.

He is recognized in Who’s Who Legal: Competition – Future Leaders, where clients have praised him as "one of the best practitioners” stressing his “litigation skills and fantastic eye for transactional work” and for being “concise, clear and just outstanding at giving oral evidence powerfully without losing any credibility.”


  • Baxter International’s antitrust strategy in its pending acquisition of Hillrom for a total enterprise value of $12.4 billion
  • ​The merger control strategy of Garrett Motion Inc. in its $2.6 billion proposed acquisition by KPS Capital Partners, its enhanced proposal from a consortium of stockholders led by Centerbridge Partners and Oaktree Capital Management, and successful emergence from Chapter 11
  • VeriFone Systems Inc. in its $3.4 billion acquisition by Francisco Partners as well as subsequent antitrust related matters
  • Temasek Holdings in its investment in Creative Artists Agency
  • Republic of Poland in an investment arbitration dispute referred to by the Swedish Supreme Court to the EU Court of Justice (Grand Chamber)
  • L3Harris Technologies in merger control proceedings for the $1.05 billion sale of its Military Training business to CAE
  • Amgen Inc. in its definitive merger agreement to acquire Five Prime Therapeutics, Inc. for approximately $1.9 billion in an all-cash transaction
  • Spirit AeroSystems in its merger control strategy for the proposed $1.1 billion acquisition of Bombardier's aerostructures and subsequent litigation proceedings at the French Conseil d'État
  • Amgen Inc. in its antitrust filings for the $13.4 billion acquisition of Otezla from Celgene
  • Amgen Inc. on the antitrust aspect of its public cash offer to the shareholders of Nuevolution AB (publ), to tender all of their shares in Nuevolution to Amgen in accordance with Swedish law and NASDAQ Stockholm’s Takeover Rules
  • Harris Corporation on the $35 billion merger of equals with L3 Technologies, Inc., the largest-ever defense industry merger
  • Harris Corporation on the divestment of Harris’s night vision devices business to Elbit Systems of America, LLC
  • Fletcher Building Limited on antitrust strategy in its agreement to sell the Formica Group to Broadview Holding BV for a sale price of US$840 million
  • Visa Europe in its successful defense against alleged collusive inter-bank fee charges, resulting in the EU Commission adopting commitments post-SO without a fine
  • UPS in pleading the first successful merger prohibition appeal at the EU Courts in 15 years (UPS/TNT)
  • UPS in its pending €1.74 billion ($2.1 billion) damages claim against the EU Commission
  • LafargeHolcim in successfully challenging Greek labor legislation at the Grand Chamber of the EU Court of Justice
  • Copelouzos in pleading the competition law part of a gas arbitration dispute against Gazprom
  • Cinven and CPPIB in successive bolt-ons, consolidating the three major players in the concentrated bedbanks sector
  • Acadia Healthcare in the UK CMA review of the completed acquisition of the Priory Group, successfully securing a Phase 1 remedies clearance
  • Holcim in the merger with Lafarge securing an unprecedented Phase I clearance with a remedy package of €6 billion